Click for best price
Nanotechnology Drug Delivery Systems Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Nanotechnology Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology Drug Delivery Systems. This report contains market size and forecasts of Nanotechnology Drug Delivery Systems in global, including the following market information:
Global Nanotechnology Drug Delivery Systems Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Nanotechnology Drug Delivery Systems market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Nanocrystals Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nanotechnology Drug Delivery Systems include AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nanotechnology Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanotechnology Drug Delivery Systems Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Nanotechnology Drug Delivery Systems Market Segment Percentages, by Type, 2022 (%)
Nanocrystals
Nanoparticles
Dendrimers
Gold Nanoparticles
Fullerenes
Liposomes
Nanotubes
Others
Global Nanotechnology Drug Delivery Systems Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Nanotechnology Drug Delivery Systems Market Segment Percentages, by Application, 2022 (%)
Immunology
Cardiovascular
Neurology
Oncology
Others
Global Nanotechnology Drug Delivery Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Nanotechnology Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanotechnology Drug Delivery Systems revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nanotechnology Drug Delivery Systems revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie, Inc.
Amgen Inc.
Celgene Corporation
Johnson & Johnson
Merck & Co., Inc.
Novartis International AG
Perrigo Company plc
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
3M
Zosano Pharma
Becton-Dickinson?BD?Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect
Vaxxas
Lohmann Therapie-Systeme AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nanotechnology Drug Delivery Systems, market overview.
Chapter 2: Global Nanotechnology Drug Delivery Systems market size in revenue.
Chapter 3: Detailed analysis of Nanotechnology Drug Delivery Systems company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nanotechnology Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nanotechnology Drug Delivery Systems Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nanotechnology Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanotechnology Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nanotechnology Drug Delivery Systems Overall Market Size
2.1 Global Nanotechnology Drug Delivery Systems Market Size: 2022 VS 2032
2.2 Global Nanotechnology Drug Delivery Systems Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nanotechnology Drug Delivery Systems Players in Global Market
3.2 Top Global Nanotechnology Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Nanotechnology Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Nanotechnology Drug Delivery Systems Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nanotechnology Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nanotechnology Drug Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Nanotechnology Drug Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Nanotechnology Drug Delivery Systems Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nanotechnology Drug Delivery Systems Market Size Markets, 2022 & 2032
4.1.2 Nanocrystals
4.1.3 Nanoparticles
4.1.4 Dendrimers
4.1.5 Gold Nanoparticles
4.1.6 Fullerenes
4.1.7 Liposomes
4.1.8 Nanotubes
4.1.9 Others
4.2 By Type - Global Nanotechnology Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Nanotechnology Drug Delivery Systems Revenue, 2018-2023
4.2.2 By Type - Global Nanotechnology Drug Delivery Systems Revenue, 2024-2032
4.2.3 By Type - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nanotechnology Drug Delivery Systems Market Size, 2022 & 2032
5.1.2 Immunology
5.1.3 Cardiovascular
5.1.4 Neurology
5.1.5 Oncology
5.1.6 Others
5.2 By Application - Global Nanotechnology Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Nanotechnology Drug Delivery Systems Revenue, 2018-2023
5.2.2 By Application - Global Nanotechnology Drug Delivery Systems Revenue, 2024-2032
5.2.3 By Application - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Nanotechnology Drug Delivery Systems Market Size, 2022 & 2032
6.2 By Region - Global Nanotechnology Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Nanotechnology Drug Delivery Systems Revenue, 2018-2023
6.2.2 By Region - Global Nanotechnology Drug Delivery Systems Revenue, 2024-2032
6.2.3 By Region - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Nanotechnology Drug Delivery Systems Revenue, 2018-2032
6.3.2 US Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.3.3 Canada Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.3.4 Mexico Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Nanotechnology Drug Delivery Systems Revenue, 2018-2032
6.4.2 Germany Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.4.3 France Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.4.4 U.K. Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.4.5 Italy Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.4.6 Russia Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.4.7 Nordic Countries Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.4.8 Benelux Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Nanotechnology Drug Delivery Systems Revenue, 2018-2032
6.5.2 China Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.5.3 Japan Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.5.4 South Korea Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.5.5 Southeast Asia Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.5.6 India Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Nanotechnology Drug Delivery Systems Revenue, 2018-2032
6.6.2 Brazil Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.6.3 Argentina Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nanotechnology Drug Delivery Systems Revenue, 2018-2032
6.7.2 Turkey Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.7.3 Israel Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.7.4 Saudi Arabia Nanotechnology Drug Delivery Systems Market Size, 2018-2032
6.7.5 UAE Nanotechnology Drug Delivery Systems Market Size, 2018-2032
7 Nanotechnology Drug Delivery Systems Companies Profiles
7.1 AbbVie, Inc.
7.1.1 AbbVie, Inc. Company Summary
7.1.2 AbbVie, Inc. Business Overview
7.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
7.1.4 AbbVie, Inc. Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.1.5 AbbVie, Inc. Key News & Latest Developments
7.2 Amgen Inc.
7.2.1 Amgen Inc. Company Summary
7.2.2 Amgen Inc. Business Overview
7.2.3 Amgen Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
7.2.4 Amgen Inc. Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.2.5 Amgen Inc. Key News & Latest Developments
7.3 Celgene Corporation
7.3.1 Celgene Corporation Company Summary
7.3.2 Celgene Corporation Business Overview
7.3.3 Celgene Corporation Nanotechnology Drug Delivery Systems Major Product Offerings
7.3.4 Celgene Corporation Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.3.5 Celgene Corporation Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Nanotechnology Drug Delivery Systems Major Product Offerings
7.4.4 Johnson & Johnson Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc. Company Summary
7.5.2 Merck & Co., Inc. Business Overview
7.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
7.5.4 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.5.5 Merck & Co., Inc. Key News & Latest Developments
7.6 Novartis International AG
7.6.1 Novartis International AG Company Summary
7.6.2 Novartis International AG Business Overview
7.6.3 Novartis International AG Nanotechnology Drug Delivery Systems Major Product Offerings
7.6.4 Novartis International AG Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.6.5 Novartis International AG Key News & Latest Developments
7.7 Perrigo Company plc
7.7.1 Perrigo Company plc Company Summary
7.7.2 Perrigo Company plc Business Overview
7.7.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Major Product Offerings
7.7.4 Perrigo Company plc Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.7.5 Perrigo Company plc Key News & Latest Developments
7.8 Pfizer, Inc.
7.8.1 Pfizer, Inc. Company Summary
7.8.2 Pfizer, Inc. Business Overview
7.8.3 Pfizer, Inc. Nanotechnology Drug Delivery Systems Major Product Offerings
7.8.4 Pfizer, Inc. Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.8.5 Pfizer, Inc. Key News & Latest Developments
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.10 3M
7.10.1 3M Company Summary
7.10.2 3M Business Overview
7.10.3 3M Nanotechnology Drug Delivery Systems Major Product Offerings
7.10.4 3M Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.10.5 3M Key News & Latest Developments
7.11 Zosano Pharma
7.11.1 Zosano Pharma Company Summary
7.11.2 Zosano Pharma Business Overview
7.11.3 Zosano Pharma Nanotechnology Drug Delivery Systems Major Product Offerings
7.11.4 Zosano Pharma Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.11.5 Zosano Pharma Key News & Latest Developments
7.12 Becton-Dickinson?BD?Technologies
7.12.1 Becton-Dickinson?BD?Technologies Company Summary
7.12.2 Becton-Dickinson?BD?Technologies Business Overview
7.12.3 Becton-Dickinson?BD?Technologies Nanotechnology Drug Delivery Systems Major Product Offerings
7.12.4 Becton-Dickinson?BD?Technologies Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.12.5 Becton-Dickinson?BD?Technologies Key News & Latest Developments
7.13 Nanopass Technologies
7.13.1 Nanopass Technologies Company Summary
7.13.2 Nanopass Technologies Business Overview
7.13.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Major Product Offerings
7.13.4 Nanopass Technologies Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.13.5 Nanopass Technologies Key News & Latest Developments
7.14 Corium
7.14.1 Corium Company Summary
7.14.2 Corium Business Overview
7.14.3 Corium Nanotechnology Drug Delivery Systems Major Product Offerings
7.14.4 Corium Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.14.5 Corium Key News & Latest Developments
7.15 Valeritas
7.15.1 Valeritas Company Summary
7.15.2 Valeritas Business Overview
7.15.3 Valeritas Nanotechnology Drug Delivery Systems Major Product Offerings
7.15.4 Valeritas Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.15.5 Valeritas Key News & Latest Developments
7.16 Nitto
7.16.1 Nitto Company Summary
7.16.2 Nitto Business Overview
7.16.3 Nitto Nanotechnology Drug Delivery Systems Major Product Offerings
7.16.4 Nitto Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.16.5 Nitto Key News & Latest Developments
7.17 Microdermics
7.17.1 Microdermics Company Summary
7.17.2 Microdermics Business Overview
7.17.3 Microdermics Nanotechnology Drug Delivery Systems Major Product Offerings
7.17.4 Microdermics Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.17.5 Microdermics Key News & Latest Developments
7.18 TheraJect
7.18.1 TheraJect Company Summary
7.18.2 TheraJect Business Overview
7.18.3 TheraJect Nanotechnology Drug Delivery Systems Major Product Offerings
7.18.4 TheraJect Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.18.5 TheraJect Key News & Latest Developments
7.19 Vaxxas
7.19.1 Vaxxas Company Summary
7.19.2 Vaxxas Business Overview
7.19.3 Vaxxas Nanotechnology Drug Delivery Systems Major Product Offerings
7.19.4 Vaxxas Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.19.5 Vaxxas Key News & Latest Developments
7.20 Lohmann Therapie-Systeme AG
7.20.1 Lohmann Therapie-Systeme AG Company Summary
7.20.2 Lohmann Therapie-Systeme AG Business Overview
7.20.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Major Product Offerings
7.20.4 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Revenue in Global Market (2018-2023)
7.20.5 Lohmann Therapie-Systeme AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nanotechnology Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Nanotechnology Drug Delivery Systems Market Drivers in Global Market
Table 3. Nanotechnology Drug Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Nanotechnology Drug Delivery Systems in Global Market
Table 5. Top Nanotechnology Drug Delivery Systems Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nanotechnology Drug Delivery Systems Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nanotechnology Drug Delivery Systems Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nanotechnology Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Nanotechnology Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanotechnology Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Nanotechnology Drug Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nanotechnology Drug Delivery Systems Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Nanotechnology Drug Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nanotechnology Drug Delivery Systems Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Nanotechnology Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nanotechnology Drug Delivery Systems Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 30. AbbVie, Inc. Company Summary
Table 31. AbbVie, Inc. Nanotechnology Drug Delivery Systems Product Offerings
Table 32. AbbVie, Inc. Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie, Inc. Key News & Latest Developments
Table 34. Amgen Inc. Company Summary
Table 35. Amgen Inc. Nanotechnology Drug Delivery Systems Product Offerings
Table 36. Amgen Inc. Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Inc. Key News & Latest Developments
Table 38. Celgene Corporation Company Summary
Table 39. Celgene Corporation Nanotechnology Drug Delivery Systems Product Offerings
Table 40. Celgene Corporation Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 41. Celgene Corporation Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Nanotechnology Drug Delivery Systems Product Offerings
Table 44. Johnson & Johnson Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Merck & Co., Inc. Company Summary
Table 47. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product Offerings
Table 48. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 49. Merck & Co., Inc. Key News & Latest Developments
Table 50. Novartis International AG Company Summary
Table 51. Novartis International AG Nanotechnology Drug Delivery Systems Product Offerings
Table 52. Novartis International AG Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis International AG Key News & Latest Developments
Table 54. Perrigo Company plc Company Summary
Table 55. Perrigo Company plc Nanotechnology Drug Delivery Systems Product Offerings
Table 56. Perrigo Company plc Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 57. Perrigo Company plc Key News & Latest Developments
Table 58. Pfizer, Inc. Company Summary
Table 59. Pfizer, Inc. Nanotechnology Drug Delivery Systems Product Offerings
Table 60. Pfizer, Inc. Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer, Inc. Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Ltd. Company Summary
Table 63. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product Offerings
Table 64. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 66. 3M Company Summary
Table 67. 3M Nanotechnology Drug Delivery Systems Product Offerings
Table 68. 3M Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 69. 3M Key News & Latest Developments
Table 70. Zosano Pharma Company Summary
Table 71. Zosano Pharma Nanotechnology Drug Delivery Systems Product Offerings
Table 72. Zosano Pharma Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 73. Zosano Pharma Key News & Latest Developments
Table 74. Becton-Dickinson?BD?Technologies Company Summary
Table 75. Becton-Dickinson?BD?Technologies Nanotechnology Drug Delivery Systems Product Offerings
Table 76. Becton-Dickinson?BD?Technologies Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 77. Becton-Dickinson?BD?Technologies Key News & Latest Developments
Table 78. Nanopass Technologies Company Summary
Table 79. Nanopass Technologies Nanotechnology Drug Delivery Systems Product Offerings
Table 80. Nanopass Technologies Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 81. Nanopass Technologies Key News & Latest Developments
Table 82. Corium Company Summary
Table 83. Corium Nanotechnology Drug Delivery Systems Product Offerings
Table 84. Corium Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 85. Corium Key News & Latest Developments
Table 86. Valeritas Company Summary
Table 87. Valeritas Nanotechnology Drug Delivery Systems Product Offerings
Table 88. Valeritas Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 89. Valeritas Key News & Latest Developments
Table 90. Nitto Company Summary
Table 91. Nitto Nanotechnology Drug Delivery Systems Product Offerings
Table 92. Nitto Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 93. Nitto Key News & Latest Developments
Table 94. Microdermics Company Summary
Table 95. Microdermics Nanotechnology Drug Delivery Systems Product Offerings
Table 96. Microdermics Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 97. Microdermics Key News & Latest Developments
Table 98. TheraJect Company Summary
Table 99. TheraJect Nanotechnology Drug Delivery Systems Product Offerings
Table 100. TheraJect Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 101. TheraJect Key News & Latest Developments
Table 102. Vaxxas Company Summary
Table 103. Vaxxas Nanotechnology Drug Delivery Systems Product Offerings
Table 104. Vaxxas Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 105. Vaxxas Key News & Latest Developments
Table 106. Lohmann Therapie-Systeme AG Company Summary
Table 107. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product Offerings
Table 108. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 109. Lohmann Therapie-Systeme AG Key News & Latest Developments
List of Figures
Figure 1. Nanotechnology Drug Delivery Systems Segment by Type in 2022
Figure 2. Nanotechnology Drug Delivery Systems Segment by Application in 2022
Figure 3. Global Nanotechnology Drug Delivery Systems Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nanotechnology Drug Delivery Systems Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Nanotechnology Drug Delivery Systems Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nanotechnology Drug Delivery Systems Revenue in 2022
Figure 8. By Type - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 9. By Application - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 10. By Type - Global Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 12. By Application - Global Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 14. By Region - Global Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 15. By Country - North America Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 16. US Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 20. Germany Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 21. France Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 28. China Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 32. India Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 34. Brazil Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Nanotechnology Drug Delivery Systems Revenue Market Share, 2018-2032
Figure 37. Turkey Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Nanotechnology Drug Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 41. AbbVie, Inc. Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Inc. Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celgene Corporation Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis International AG Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Perrigo Company plc Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer, Inc. Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. 3M Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Zosano Pharma Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Becton-Dickinson?BD?Technologies Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Nanopass Technologies Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Corium Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Valeritas Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Nitto Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Microdermics Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. TheraJect Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Vaxxas Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
